These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20706845)

  • 1. Intracranial hypertension following intrathecal administration of liposomal cytarabine.
    Lunskens S; Lammertijn L; Deeren D; Bergmans B; Maertens J; Vandenberghe R
    J Neurol; 2011 Jan; 258(1):162-3. PubMed ID: 20706845
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometric detection of liposomal cytarabine in cerebrospinal fluid of patients treated with intrathecal chemotherapy.
    Stacchini A; Demurtas A; Aliberti S
    Cytometry B Clin Cytom; 2012 Sep; 82(5):280-2. PubMed ID: 22539249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
    Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
    Valentin A; Troppan K; Pfeilstöcker M; Nösslinger T; Linkesch W; Neumeister P
    Leuk Lymphoma; 2014 Aug; 55(8):1739-42. PubMed ID: 24138308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
    Bassan R; Masciulli A; Intermesoli T; Audisio E; Rossi G; Pogliani EM; Cassibba V; Mattei D; Romani C; Cortelezzi A; Corti C; Scattolin AM; Spinelli O; Tosi M; Parolini M; Marmont F; Borlenghi E; Fumagalli M; Cortelazzo S; Gallamini A; Marfisi RM; Oldani E; Rambaldi A
    Haematologica; 2015 Jun; 100(6):786-93. PubMed ID: 25749825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
    Hartz B; Löbel U; Hagel C; Escherich G
    Am J Hematol; 2013 Dec; 88(12):1096-7. PubMed ID: 23873785
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant chemical ventriculomeningitis following intrathecal liposomal cytarabine administration.
    Butto A; Al-Holou WN; Junck L; Sagher O; Fletcher JJ
    J Clin Neurosci; 2011 Oct; 18(10):1417-8. PubMed ID: 21764318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
    Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C
    Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of liposomal cytarabine in neoplastic meningitis].
    Rudà R; Leoncini B; Laguzzi E; Trevisan E; Guarneri D; Bertetto O; Soffietti R
    Tumori; 2007; 93(3):suppl 4-5. PubMed ID: 17679479
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
    Benesch M; Siegler N; Hoff Kv; Lassay L; Kropshofer G; Müller H; Sommer C; Rutkowski S; Fleischhack G; Urban C
    Anticancer Drugs; 2009 Oct; 20(9):794-9. PubMed ID: 19617818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
    Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
    J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accidental overdose of intrathecal cytarabine in children.
    Thienprayoon R; Heym KM; Pelfrey L; Bowers DC
    Ann Pharmacother; 2013 May; 47(5):e24. PubMed ID: 23606548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Cartier R L; Parra V J; Puga B; Cardemil D
    Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
    Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
    Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
    Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.
    Peyrl A; Sauermann R; Chocholous M; Azizi AA; Jäger W; Höferl M; Slavc I
    Clin Pharmacokinet; 2014 Feb; 53(2):165-73. PubMed ID: 24129691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
    Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
    Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.